PMID,Title,Citation_Count,Authors,Journal,Year,DOI,DOI_Link,PDF_Link,PubMed_URL
38786024,CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments.,32,"Laurent M, Geoffroy M, Pavani G",Cells,2024,10.3390/cells13100800,https://doi.org/10.3390/cells13100800,https://storage.cloud.google.com/calidoscope-data-03/pubmed_pdf_kftang/38/78/38786024.PMC11119143.pdf,https://pubmed.ncbi.nlm.nih.gov/38786024/
27699445,CRISPR/Cas9 Immune System as a Tool for Genome Engineering.,78,"Hryhorowicz M, Lipiński D, Zeyland J",Archivum immunologiae et therapiae experimentalis,2016,10.1007/s00005-016-0427-5,https://doi.org/10.1007/s00005-016-0427-5,https://storage.cloud.google.com/calidoscope-data-03/pubmed_pdf_kftang/27/69/27699445.PMC5434172.pdf,https://pubmed.ncbi.nlm.nih.gov/27699445/
26470680,Advances in therapeutic CRISPR/Cas9 genome editing.,101,"Savić N, Schwank G",Translational research : the journal of laboratory and clinical medicine,2015,10.1016/j.trsl.2015.09.008,https://doi.org/10.1016/j.trsl.2015.09.008,N/A,https://pubmed.ncbi.nlm.nih.gov/26470680/
30912037,Tracking CRISPR's Footprints.,5,"Lin L, Luo Y","Methods in molecular biology (Clifton, N.J.)",N/A,10.1007/978-1-4939-9170-9_2,https://doi.org/10.1007/978-1-4939-9170-9_2,N/A,https://pubmed.ncbi.nlm.nih.gov/30912037/
27250031,CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.,48,"Khan FA, Pandupuspitasari NS, Chun-Jie H",Oncotarget,N/A,10.18632/oncotarget.9646,https://doi.org/10.18632/oncotarget.9646,https://storage.cloud.google.com/calidoscope-data-03/pubmed_pdf_kftang/27/25/27250031.PMC5239572.pdf,https://pubmed.ncbi.nlm.nih.gov/27250031/
